Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the schedule hereto:
Schedule
Product: Lantus
Active Ingredient(s): Insulin Glargine 100IU/mL equivalent to 3.6378mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Aventis Pharma Limited
Manufacturer(s): Aventis Pharma Deutschland GmbH, Frankfurt am Main, Germany
Dated this 13th day of June 2001.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).